Data updated to May 21, 2021
Humanity faces the largest vaccination campaign in history. The immunization process against Covid-19, which began in early December in the United States, United Kingdom, Russia and China, is underway around the world and stands out in most of the richest countries.
Spain started on December 27 the administration of the Pfizer doses, in mid-January those of Moderna began to be inoculated as well, and in February those of AstraZeneca. All three vaccines are double-dose: they require two pricks separated by a period of several weeks. Those of Janssen were the last serums to begin to be administered in our country, which only requires one injection.
Since the campaign began, the first people to receive the vaccine were the elderly residents in senior centers, as well as first-line health personnel and large dependents. As the vaccination process has advanced, doses of the different sera have been inoculated to the rest of the general population, prioritizing the older age groups.
The following table shows the status of the vaccination process in Spain in each autonomous community. The percentage of the population completely vaccinated, the percentage of the population with at least one dose of the vaccine, the percentage of doses administered over those received in each autonomous community, the number of injected doses and the registered date of the last dose administered are shown.
From flattening to accelerating the curve
When the pandemic began, there was a main objective for all the countries of the world: to flatten the contagion curve. With the advent of vaccines, the goal is to accelerate the vaccination curve to immunize millions of people in record time – a logistical and medical challenge never before done on a global scale.
Over the weeks, it has been shown that the bottleneck of vaccination in Spain are the doses received. This is how the vaccination rate in Spain evolves, measured in the average daily doses administered in the last week.
Although currently a good rate of vaccination has been achieved, the process began at different speeds between autonomous communities, since each one can apply different vaccination strategies. For example, the territories that have a higher population with priority to vaccinate (residences, toilets and over 60 years) have received more doses per inhabitant and have been able to vaccinate a greater part of the population.
To find out how the process is progressing and how much population is immunized in each region, the following graph shows the detail by communities. In it you can see how many people have received at least one dose or the complete vaccine, and the percentage they represent of the total population to be immunized in each region.
How is the vaccination process evolving in your autonomous community? How many people have received at least one dose of the vaccine? And the complete guideline? How long will it take to immunize 70% of the population? In the following tabs you can consult all the details, region by region.
The age groups with the most advanced vaccination
Vaccination of the different age groups progresses at a different rate in each autonomous community. Those over 80 were the first to start receiving the serums; AstraZeneca doses were subsequently prioritized for essential workers and octogenarians. With the arrival of Janssen began vaccinating people between 50 and 59 years old in May. As for the youngest, vaccination in minors is getting closer, but they are still the last priority.
The following table allows you to consult the evolution of vaccination in each age group according to the percentage of the population that has received at least one dose or the complete vaccination schedule.
The effect of vaccination on mortality
The doses inoculated in Spain are already beginning to pay off. When analyzing the mortality curve, infections and hospitalizations of each age group, it is clearly observed how mortality among those over 80 years of age (the first to receive the vaccine) has significantly reduced than among the rest of the population. To a lesser extent, a greater reduction in cases and hospitalizations is also seen in this age group. Each curve is adjusted with respect to the maximum peak that each group recorded in the third wave.
The road to immunity in the world
Millions of people in a small number of countries around the world have already received at least one dose of some Covid-19 vaccine. The campaign began in many countries in December with emergency authorizations, in some cases using experimental drugs, and it has accelerated in recent weeks with the authorizations of several vaccines in the European Union and the rest of the world.
The following map shows the countries that have administered the most doses per 100 inhabitants worldwide. Only the figures for the countries that have published data are shown, according to the data collected by the portal Our World in Data.
The vaccination gap between rich and poor countries is beginning to show in the figures. So far, the majority of doses administered worldwide are concentrated in the Northern Hemisphere: virtually all of Europe has started vaccinating along with the United States, Canada and much of the Middle East. Precisely, Israel leads the vaccination campaign around the world with 50,000 daily doses which is explained by the digitization of the health system, the distribution of doses to avoid waste and centralization. This table includes the percentage of immunized people in each country, a figure that may differ from the doses per 100 inhabitants, since in many countries vaccines that require two doses are being administered. This percentage cannot be calculated for countries that do not show separately the number of administered doses of each type of vaccine.
The difference between Israel’s vaccination curve and that of other countries is wide. Although the size and population of each country must also be taken into account to make comparisons: it is not the same to vaccinate 8 million people who live concentrated in 22,000 square kilometers than to vaccinate 47 million people who live in 500,000 square kilometers Of surface. To date, Pfizer’s vaccine is the most widespread in Europe and the United States, where Moderna’s vaccine is also being administered. The Oxford / AstraZeneca has also started in the UK. Instead China, India and Russia are using their own drugs that are also distributed by Latin America.
The economic gap becomes more visible when the doses administered are grouped by regions of the world. The vaccination process has barely begun in Latin America and Africa, compared to the countries with the highest per capita income, which accounted for the majority of doses purchased before vaccines were approved.